Schistosoma infection, KRAS mutation status, and prognosis of colorectal cancer.

Author: Xinyi LI ¹ ; Hongli LIU ² ; Bo HUANG ¹ ; Ming YANG ¹ ; Jun FAN ¹ ; Jiwei ZHANG ¹ ; Mixia WENG ¹ ; Zhecheng YAN ¹ ; Li LIU ³ ; Kailin CAI ⁴ ; Xiu NIE ¹ ; Xiaona CHANG ¹
Author Information

1. Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
2. Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
3. Department of Epidemiology and Biostatistics, The Ministry of Education Key Lab of Environment and Health, School of Public Health, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
4. Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
Publication Type:Journal Article
MeSH: Humans; Proto-Oncogene Proteins p21(ras)/genetics*; Prognosis; Biomarkers, Tumor/genetics*; Mutation/genetics*; Colorectal Neoplasms/genetics*; Proto-Oncogene Proteins B-raf/metabolism*
From: Chinese Medical Journal 2024;137(2):235-237
CountryChina
Language:English